Amyris announced JV partnership with ImmunityBio for next generation COVID-19 RNA vaccine

, ,

On Nov. 8, 2021, Amyris announced announced it had entered into a 50:50 joint venture arrangement with ImmunityBio to accelerate the commercialization of a leading next-generation COVID-19 vaccine.

Tags:

Source: Amyris
Credit:

Visit News/History Source
LifeScienceHistory.com offers three advertising package options. Each package lnclude at least two digital images for multiple page placements and maximum exposure! Rates range from just $300 to $500 per month.